nanosynth group plc Stock

AERO

GB00BFX0ZN92

Biotechnology & Medical Research

Latest news: nanosynth group plc

23-10-03	EARNINGS AND TRADING: nanosynth shares remain suspended on AIM	AN
23-08-30	Nanosynth CFO Andrew Stedman steps down with immediate effect	AN
23-08-30	Nanosynth Announces Resignation of Andrew Stedman as Chief Financial Officer	CI
23-07-28	Jardine Matheson net assets rise, Oberon loss widens	AN
23-07-28	Nanosynth group plc Announces Executive Changes	CI
23-07-28	Nanosynth group plc Announces Resignation of Mark Duffin from the Board	CI
23-06-26	WANDisco in extra cost savings; SRT raises GBP750,000	AN
23-05-16	Trinity Exploration spuds well; Equipmake inks deal	AN
23-05-16	UK nanotech firm Nanosynth proposes to enter voluntary liquidation	RE
23-05-16	Nanosynth Plans Voluntary Liquidation; London Shares Surge Before Trading Halt	MT
23-05-16	UK nanotech firm Nanosynth proposes to enter voluntary liquidation	RE
23-05-16	Nanosynth Group Announces Proposal To Appoint Liquidators	RE
23-04-06	Nanosynth shares plummet on lack of cash resources	AN

More news

Managers and Directors: nanosynth group plc

Manager	Title	Age	Since
Gareth Cave CEO	Chief Executive Officer	51	2023-07-27
Gary Dennis Nel CTO	Chief Tech/Sci/R&D Officer	-	-
Linda Saleh HRO	Human Resources Officer	-	2021-12-31

Director	Title	Age	Since
Gareth Cave BRD	Director/Board Member	51	2021-04-18
Felicity Sartain BRD	Director/Board Member	46	2021-04-18
Peter Gray BRD	Director/Board Member	65	2022-06-29

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NANOSYNTH GROUP PLC	+47.54%	+47.54%	-	-	3.26M
WUXI APPTEC CO., LTD.	-3.10%	-4.19%	+32.67%	+59.47%	65.28B
ARGENX SE	+0.33%	+0.33%	+10.16%	+78.07%	54.57B
LONZA GROUP AG	+0.16%	+1.73%	+9.89%	+102.10%	53.59B
IQVIA HOLDINGS INC.	-0.75%	+1.38%	+24.89%	+50.91%	45.03B
BEONE MEDICINES AG	-1.30%	-4.80%	+16.05%	+114.76%	42.17B
REVOLUTION MEDICINES, INC.	+1.26%	-5.26%	+221.12%	+900.64%	39.42B
CELLTRION, INC.	-0.74%	-4.46%	+11.00%	+44.65%	32.71B
GENMAB A/S	+1.11%	+15.18%	+60.27%	+49.33%	26.5B
WUXI BIOLOGICS (CAYMAN) INC.	+2.28%	-7.61%	+24.16%	-9.62%	24.01B
Average	+4.67%	-0.17%	+45.58%	+154.48%	42.59B
Weighted average by Cap.	-0.41%	-0.59%	+42.44%	+153.37%

See all sector performances

nanosynth group plc is a United Kingdom-based nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. The Company specializes in the synthesis and application of nanoparticles to create new and improve existing products. The Company is focused on developing commercial applications to enhance existing products and to develop new products, leveraging its platform nanotechnology and material science across a range of industry sectors and markets. It uses patented technology to reproducibly synthesize and functionalize nanoparticles that are homogenous. Its technology developed at Nottingham Trent University, uses a spinning disk reactor to control both the size and shape of the nanoparticles, making its process efficient and scalable for a variety of applications. The Company has two operating subsidiaries, Nanovate Ltd and Virosynth Ltd, each of which is focused on specific industry applications of the core technology.

Employees

Sector

Biotechnology & Medical Research

More about the company